| Year |
Citation |
Score |
| 2024 |
Qie S, Xiong H, Liu Y, Yan C, Wang Y, Tian L, Wang C, Sang N. Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Research Square. PMID 38464261 DOI: 10.21203/rs.3.rs-3904465/v1 |
0.721 |
|
| 2023 |
Zhao M, Huang C, Yang L, Pan B, Yang S, Chang J, Jin Y, Zhao G, Yue D, Qie S, Ren L. SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma. Cell Death & Disease. 14: 666. PMID 37816756 DOI: 10.1038/s41419-023-06208-x |
0.306 |
|
| 2022 |
Mucha B, Qie S, Bajpai S, Tarallo V, Diehl JN, Tedeschi F, Zhou G, Gao Z, Flashner S, Klein-Szanto AJ, Hibshoosh H, Masataka S, Chajewski OS, Majsterek I, Pytel D, et al. Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation. Nature Communications. 13: 6614. PMID 36329064 DOI: 10.1038/s41467-022-34402-6 |
0.332 |
|
| 2022 |
Qie S. The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives. Cancers. 14. PMID 35565262 DOI: 10.3390/cancers14092133 |
0.345 |
|
| 2022 |
Qie S, Sang N. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. Journal of Experimental & Clinical Cancer Research : Cr. 41: 161. PMID 35501821 DOI: 10.1186/s13046-022-02370-w |
0.685 |
|
| 2019 |
He H, Qie S, Guo Q, Chen S, Zou C, Lu T, Su Y, Zong J, Xu H, He D, Xu Y, Chen B, Pan J, Sang N, Lin S. Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells. Cancer Management and Research. 11: 6411-6424. PMID 31372045 DOI: 10.2147/Cmar.S197607 |
0.704 |
|
| 2019 |
Qie S, Yoshida A, Parnham S, Oleinik N, Beeson GC, Beeson CC, Ogretmen B, Bass AJ, Wong KK, Rustgi AK, Diehl JA. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nature Communications. 10: 1296. PMID 30899002 DOI: 10.1038/S41467-019-09179-W |
0.335 |
|
| 2019 |
Qie S, He D, Sang N. Overview of Glutamine Dependency and Metabolic Rescue Protocols. Methods in Molecular Biology (Clifton, N.J.). 1928: 427-439. PMID 30725468 DOI: 10.1007/978-1-4939-9027-6_22 |
0.703 |
|
| 2018 |
Gennaro VJ, Stanek TJ, Peck AR, Sun Y, Wang F, Qie S, Knudsen KE, Rui H, Butt T, Diehl JA, McMahon SB. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 30224477 DOI: 10.1073/Pnas.1807704115 |
0.453 |
|
| 2017 |
Qie S, Majumder M, Mackiewicz K, Howley BV, Peterson YK, Howe PH, Palanisamy V, Diehl JA. Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma. Nature Communications. 8: 1534. PMID 29142209 DOI: 10.1038/s41467-017-01199-8 |
0.327 |
|
| 2017 |
He D, Yin C, Qie S, Chen S, Sang N. Abstract 3562: A novel TGF-β signaling pathway promotes a slow growing phenotype of cancer cells in response to glutamine insufficiency Cancer Research. 77: 3562-3562. DOI: 10.1158/1538-7445.Am2017-3562 |
0.694 |
|
| 2016 |
Pytel D, Gao Y, Mackiewicz K, Katlinskaya YV, Staschke KA, Paredes MC, Yoshida A, Qie S, Zhang G, Chajewski OS, Wu L, Majsterek I, Herlyn M, Fuchs SY, Diehl JA. PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma. Plos Genetics. 12: e1006518. PMID 27977682 DOI: 10.1371/Journal.Pgen.1006518 |
0.389 |
|
| 2016 |
Majumder M, House R, Palanisamy N, Qie S, Day TA, Neskey D, Diehl JA, Palanisamy V. RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC. Plos Genetics. 12: e1006306. PMID 27606879 DOI: 10.1371/journal.pgen.1006306 |
0.325 |
|
| 2014 |
Qie S, Chu C, Li W, Wang C, Sang N. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation. Journal of Cellular Biochemistry. 115: 498-509. PMID 24122876 DOI: 10.1002/Jcb.24684 |
0.727 |
|
| 2013 |
Qie S, Tian L, Wang C, Sang N. Abstract LB-135: Stanniocalcin 2 attenuates tumor cell proliferation but suppresses apoptosis in nutrient-deprived conditions. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-135 |
0.732 |
|
| 2012 |
Qie S, Liang D, Yin C, Gu W, Meng M, Wang C, Sang N. Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming. Cell Cycle (Georgetown, Tex.). 11: 3679-90. PMID 22935705 DOI: 10.4161/Cc.21944 |
0.712 |
|
| 2012 |
Yin C, Qie S, Sang N. Carbon source metabolism and its regulation in cancer cells. Critical Reviews in Eukaryotic Gene Expression. 22: 17-35. PMID 22339657 DOI: 10.1615/Critreveukargeneexpr.V22.I1.20 |
0.704 |
|
| 2012 |
Qie S, Chu C, Li W, Wang C, Reginato M, Sang N. Abstract 5143: ErbB2 activation up-regulates glutaminase 1 expression via NF-κB pathway Cancer Research. 72: 5143-5143. DOI: 10.1158/1538-7445.Am2012-5143 |
0.729 |
|
| 2011 |
Qie S, Sang N. Release the ink4a/arf growth suppression by "u" and "me"? Cell Cycle (Georgetown, Tex.). 10: 185-6. PMID 21239875 DOI: 10.4161/Cc.10.2.14471 |
0.714 |
|
| 2008 |
Sun T, Sun BC, Ni CS, Zhao XL, Wang XH, Qie S, Zhang DF, Gu Q, Qi H, Zhao N. Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells. Cancer Letters. 263: 35-43. PMID 18234417 DOI: 10.1016/j.canlet.2007.12.015 |
0.328 |
|
| Show low-probability matches. |